Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD)

Recruiting Observational Study
Birdshot Chorioretinopathy Posterior Uveitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
600 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is twofold: 1. To analyze the clinical features of a cohort of patients with birdshot chorioretinopathy (BCR), an inflammatory bilateral ocular disease, affecting the choroid and the retina. Various imaging techniques will be used to assess the effect of the disease on the retina and the choroid. A standardized assessment of the visual function will be performed …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Bilateral disease 2. Presence of at least three peripapillary "birdshot lesions" inferior or nasal to the optic disk in one eye 3. Low-grade anterior segment intraocular inflammation (defined as ≤ 1+cells in the anterior chamber) 4. Low grade vitreous inflammatory reaction (d…
Contacts

Souhila KECILI, MSc

+33 1 58412898

souhila.kecili@aphp.fr

CONTACT

Guillaume MASSON

+33 1 58413478

guillaume.masson@aphp.fr

CONTACT